Literature DB >> 7760367

Subunit expression of signal transducing G proteins in cardiac tissue: implications for phospholipase C-beta regulation.

C A Hansen1, A G Schroering, J D Robishaw.   

Abstract

In the heart, alpha-adrenergic, angiotensin II and endothelin signaling pathways modulate short-term changes in chronotropy and inotropy, and participate in the long-term control of cardiac growth. A shared feature of these signaling pathways is the stimulation of phosphatidylinositol (PI) turnover, which is thought to occur via G protein-mediated regulation of phospholipase C (PLC) activity. However, G protein subunits capable of regulating PLC activity have not been identified in different regions and cell types of the heart and members of the G protein-regulated PLC-beta isozyme family have not been documented in the heart. Using a battery of antipeptide specific antisera directed against the G protein alpha q, beta and gamma subunit families and against members of the PLC-beta, PLC-gamma and PLC-delta families, we demonstrated that heart tissues express the G protein alpha subunits alpha q and alpha 11, multiple G protein beta and gamma subunits, and PLC-beta 3, a phospholipase C isozyme regulated by either G protein alpha or beta gamma subunits. The degree of expression and distribution of these subunits differed between regions of the heart (atria versus ventricle) and changed with development. These data lay the ground work for future studies to determine the functional coupling of specific subsets of these components involved in receptor activation of PI turnover in the heart.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760367     DOI: 10.1016/s0022-2828(08)80043-0

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  12 in total

1.  A G protein gamma subunit peptide stabilizes a novel muscarinic receptor state.

Authors:  I Azpiazu; N Gautam
Journal:  Biochem Biophys Res Commun       Date:  2006-01-30       Impact factor: 3.575

2.  G protein betagamma dimer expression in cardiomyocytes: developmental acquisition of Gbeta3.

Authors:  Vitalyi O Rybin; Susan F Steinberg
Journal:  Biochem Biophys Res Commun       Date:  2008-01-31       Impact factor: 3.575

Review 3.  Regulation of G protein function: implications for heart disease.

Authors:  J T Meij
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

4.  Isoprenaline can activate the acetylcholine-induced K+ current in canine atrial myocytes via Gs-derived betagamma subunits.

Authors:  S Sorota; I Rybina; A Yamamoto; X Y Du
Journal:  J Physiol       Date:  1999-01-15       Impact factor: 5.182

5.  Purinergic stimulation of rat cardiomyocytes induces tyrosine phosphorylation and membrane association of phospholipase C gamma: a major mechanism for InsP3 generation.

Authors:  M Puceat; G Vassort
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  Analysis of inositol phosphates in heart tissue using anion-exchange high-performance liquid chromatography.

Authors:  E A Woodcock
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

7.  G-protein betagamma subunits antagonize protein kinase C-dependent phosphorylation and inhibition of phospholipase C-beta1.

Authors:  I Litosch
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 8.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

9.  Muscarinic K+ channel in the heart. Modal regulation by G protein beta gamma subunits.

Authors:  T T Ivanova-Nikolova; E N Nikolov; C Hansen; J D Robishaw
Journal:  J Gen Physiol       Date:  1998-08       Impact factor: 4.086

10.  Myocyte-specific M-CAT and MEF-1 elements regulate G-protein gamma 3 gene (gamma3) expression in cardiac myocytes.

Authors:  Charlene McWhinney; Janet D Robishaw
Journal:  DNA Cell Biol       Date:  2008-07       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.